Chemical modification of ansamitocins. II. Synthesis of 3-epimaytansionoids via 3-maytansinones

DOI: 10.1248/cpb.32.2773

Source and publish data:

Chemical and Pharmaceutical Bulletin p. 2565 - 2570 (1984)

Update date:2022-09-26

Topics:

Authors:

Akimoto Akimoto

Kawai Kawai

Hashimoto

Nomura Nomura

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1248/cpb.32.2773

Full text of DOI:10.1248/cpb.32.2773

NII-Electronic Library Service

Products guided by the article

Product name:3-epimaytansinol 3-phenylacetate

Cas No:72887-70-8

R&D Labs maybe for 72887-70-8

Hefei TNJ chemical industry co.,ltd

website:https://www.tnjchem.com

Contact:+86-551-65418695

Address:B911 Xincheng Business Center, Qianshan Road, Hefei Anhui China
shanghai hekang chemical co.ltd

Contact:021-54173790

Address:328 WuHe Road, Building #A, 2nd Floor, Minhang, Shanghai 201109, China
Hangzhou Neway Chemicals Co., Ltd.

Contact:+86-571-85095566

Address:Room 803, Qinglian Bldg, No 139 Qingchun Road, Hangzhou, Zhejiang China
Shanghai He Yang International Trading Co., Ltd.

Contact:+86-21-52043598

Address:Room 816, Blag.5, No.58 Huachi Road
Rugao Jinling Chemical Co., Ltd.(expird)

Contact:0086-513-68005586

Address:Lianluo new village huangshi town Rugao city Jiangsu Province.

Relevant to this article

DABCO-mediated decarboxylative cyclization of isatoic anhydride with aroyl/heteroaroyl/alkoylacetonitriles under microwave conditions: Strategy for the synthesis of substituted 4-quinolones

Doi:10.1016/j.tetlet.2021.153187
(2021)
Site- And enantiodifferentiating C(sp³)-H oxidation enables asymmetric access to structurally and stereochemically diverse saturated cyclic ethers

Doi:10.1021/jacs.0c09636
(2020)
Doi:10.1021/jo01017a020
(1965)
ACID-CATALYSED MONOACETYLATION OF TWO 3-DEOXYHEXITOLS

Doi:10.1016/0008-6215(80)90004-X
(1980)
Development of a Strategy for Convergent Total Synthesis of the Aureolic Acid Antitumor Antibiotics

Doi:10.1021/jo00142a009
(1982)
Conformation-based restrictions and scaffold replacements in the design of hepatitis C virus polymerase inhibitors: Discovery of deleobuvir (BI 207127)

Doi:10.1021/jm4011862
(2014)

Article Doi